Risk assessment in pulmonary arterial hypertension
Marius M. Hoeper, David Pittrow, Christian Opitz, J. Simon R. Gibbs, Stephan Rosenkranz, Ekkehard Grünig, Karen M. Olsson, Doerte Huscher
European Respiratory Journal 2018 51: 1702606; DOI: 10.1183/13993003.02606-2017
Marius M. Hoeper
1Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany
2German Center of Lung Research (DZL), Germany
David Pittrow
3Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany
Christian Opitz
4Dept of Cardiology, DRK Kliniken Berlin Westend, Berlin, Germany
J. Simon R. Gibbs
5Dept of Cardiology, National Heart and Lung Institute, Imperial College London, London, UK
Stephan Rosenkranz
6Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine (CMMC), University of Cologne, Cologne, Germany
7The Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany
Ekkehard Grünig
2German Center of Lung Research (DZL), Germany
8Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany
Karen M. Olsson
1Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany
2German Center of Lung Research (DZL), Germany
Doerte Huscher
9Epidemiology Unit, German Rheumatism Research Centre, A. Leibniz Institute, Berlin, Germany
Vol 51 Issue 3
Table of Contents
Risk assessment in pulmonary arterial hypertension
Marius M. Hoeper, David Pittrow, Christian Opitz, J. Simon R. Gibbs, Stephan Rosenkranz, Ekkehard Grünig, Karen M. Olsson, Doerte Huscher
European Respiratory Journal Mar 2018, 51 (3) 1702606; DOI: 10.1183/13993003.02606-2017